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Abstract
Objective: The aim of this prospective controlled study is the comparison between  long-term children survived 
leukaemia and a control group in terms of the decayed, missing or filled permanent teeth (DMFT) and dental 
anomalies. 
Study design: Fifty-two long term children survived leukaemia, aged from 8 to 15 years (27 females, 25 males; 
mean age 11.5 years) were evaluated for the possible effects of the anti-leukaemic therapy on dental development 
and compared  to a control group of 52 healthy children (27 females, 25 males, mean age 11 years). All long-term 
children who survived were at least 24 months in continuous complete remission. The study of the dental status 
with a routine oral examination and panoramic radiographs was performed. The DMFT (recorded according to 
the WHO criteria) and dental anomalies were registered and evaluated.
Results: The results of this study evidence that long-term children survived leukaemia, in comparison with the 
control group, have an higher risk to develop dental caries and show a greater  severity of dental anomalies includ-
ing V-shaped roots, dental agenesis, microdontia, enamel dysplasias. 
Conclusions: Paediatric patients with haemathological diseases require a special attentions in dental care in addi-
tion to the antineoplastic treatment. Therefore, oral hygiene and oral health can be maintained thanks to a close 
cooperation between the paediatric oncohaematologists, pediatrics dental surgeons and dental hygienists.
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Introduction
The rate of children who survived cancer, has conside-
rably improved and a serious effort has been made to 
avoid the late and side effects of antineoplastic therapies 
(1). The oral cavity in malignant diseases treated ado-
lescents and young adults shows frequently the signs 
of the past disease and its anti-neoplastic therapy. The 
acute leukaemias in children are a classic example of 
this assertion. Leukaemia constitutes approximately 
30% of all childhood cancers and acute lymphoblastic 
leukaemia (ALL) is the most common type of malig-
nancy (2). On the other hand, acute myeloblastic leu-
kaemia (AML) is a group of malignant bone marrow 
neoplasms of myeloid precursors of white blood cells. 
AML is rare and represents approximately 5% of all 
childhood leukaemias and has an incidence of 1.6 - 2.2 
per million per year (3).
The treatment of haematological malignancy involves 
chemotherapy, radiotherapy and/or bone marrow trans-
plants: this therapeutic approach can cause a real stig-
mata in the survived patients and can affect their quality 
of life. The data about oral and dental health of paedi-
atric patients affected by acute leukaemias and subse-
quently healed, are sparse and their levels of evidence is 
not always adequate. (4-9) The aim of this prospective 
controlled study is to describe the oral and dental status 
of long term childhood leukaemia survivors followed-
up at the dental clinic of university of Milan-Bicocca, 
compared with a control group. 
Material and Methods
Fifty-two children in long-term remission, previously 
ALL and AML treated at the Division of Haematology-
Oncology, Department of Paediatrics of Milano Bicocca 
University, were included in this prospective study. The 
survey was performed in the dental clinic of university 
of Milan-Bicocca. A written consent was given by each 
patient. The study has been conducted according to e-
thical principles of the declaration of Helsinki.
Demographic data, leukaemic treatment regimen, du-
ration of leukaemia remission and type of leukaemia 
(ALL or AML) were recorded for each patient. 
The DMFT (Decayed, Missing, Filled Teeth) score was 
recorded at least 24 months after the end of leukaemic 
treatment regimen, according to WHO recommenda-
tions. Caries lesions were scored by two blinded cali-
brated examiners who worked in pair: the first visited 
and the second collected data. Dental anomalies as 
microdontia, enamel hypoplasia, dental agenesis and 
V-shaped roots were assessed according to clinical and 
radiological examination. A panoramic X-ray was per-
formed in all fifty-two cases.
Children did not receive any fluoride supplement or 
chlorhexidine treatment during or after the leukaemic 
treatment.
Moreover, for each patient, age and sex matched con-
trol was chosen randomly among school children with a 
similar socio-economic background attending at dental 
clinic of university of Milan-Bicocca.
-Statistical analysis
Data were analysed using statistical software (STATA 
version 10.1. USA). Chi-square test  was used to compare 
the prevalence of the DMFT index and dental anomalies 
in the patients and control group. Differences and cor-
relations were considered significant if p<0.05. 
Results
Of the 52 patients enrolled 25 were men and 27 women 
and the mean age was (mean11.5 ±3.5 years). Thirty-
nine patients were affected by ALL, the remaining ones 
were affected by AML. The mean duration of leukae-
mia remission was 60± 24 months.
Patients were treated according to Italian Association of 
Paediatric Hematoncology (AIEOP) (10) standard pro-
tocol, showed in table 1.
Seven patients with ALL received cranial irradiation (18 
Gy) in addition to chemotherapy and cytotoxic treatment.
Data about DMFT and dental anomalies in patients and 
control group are reported in table 2.
Asparaginase 5000 U/m2 3x3 weeks
Methotrexate 12,5 mg IT
Vincristine 1,5 mg/m2 1x4 weeks
Daunoblastine 30 mg/m2 2 days
Prednisone 60 mg/m2 7 weeks
Desamethasone 10 mg/m2 7 weeks
Table 1. Italian Association of Paediatric Hematoncology(AIEOP) 
protocol.
Leukaemic 
survivors
control 
group
p value
DMFT 8.3 4.5 0.03
Microdontia
patients number (%)
12 (23%) 4 (7.6%) 0.03
enamel hypoplasia
patients number (%)
9 (17.3%) 2 (3.8%) 0.02
dental agenesis 
patients number (%)
7 (13.4%) 2 (3.8%) 0.03
V-shaped roots
patients number (%)
8 (5.3%) 1 (1.9%) 0.02
Table 2. DMFT and Dental anomalies in study and control group.
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DMFT was significantly higher in the leukaemic survi-
vors than in the control group (8.3 versus 4.5; p=0.03). 
Upper incisors, canine and premolars were the most 
frequent microdontic teeth: twelve leukaemic survi-
vors (23%) showed this dental anomaly while only four 
subjects (7.6%) in the control group, were positive. The 
difference was statistically significant (p=0.03). Ena-
mel hypoplasia was found in nine leukaemic survivors 
(17%) mainly on the upper lateral incisors and molars. 
In the control group we found only two (3.8%) subjects 
affected by enamel hypoplasia. Also in this case, the 
difference was significant (p=0.02). Seven leukaemic 
survivors (13%) showed dental agenesis compared to 
two subjects (3.8%) in the control group (p=0.03). V-
shaped roots (above all lower incisors) were found in 
eight (15.3%) leukaemic survivors compared with only 
one subject in the control group. The calculated diffe-
rence was statistically significant (p=0.02). 
Discussion
The aim of this study was to investigate the DMFT in-
dex and the dental anomalies caused by ALL and AML 
treatment. To the best of our knowledge, this is the first 
prospective study on this topic, conducted in Italy in 
the last 10 years. In paediatric leukaemic survivors, the 
DMFT index is worse than in the control group. Den-
tal anomalies as hypoplasia, agenesis observed in all 
ALL and AML treated patients are more frequent than 
in healthy subjects. The incidence of anomalies in struc-
ture, number, size, and shape of teeth are in agreement 
with the data reported in other studies (4-9). We found 
additional evidences according to which the dental de-
velopment is affected by the leukaemia treatment, apart 
from the patients who were undertaken chemotherapy, 
radiotherapy, bone marrow transplantation or a combina-
tion of these (11-14). Moreover, this study used a matched 
control group other than siblings in order to reduce the 
number of variables that might affect results, such as he-
reditary factors, familiar, diet and hygiene habits.
As far as we know, the DMFT score were rarely investiga-
ted in patients with haematological disease. Our results 
suggest that previous antineoplastic therapies have a nega-
tive impact on the dental status of the patients and confirm 
the observations of other authors who reported an increased 
DMFT value in leukaemia treated children (15,16).
The negative impact of cytostatic drugs on the oral 
mucosa as well as the poor oral hygiene, observed dur-
ing the chemotherapy, are the main causes of the oral 
health decline. Reduced salivary flow induced changes 
in the spectrum of bacteria colonizing the oral cavity 
and favoured caries-related microflora (17). Another 
consequence of hyposalivation is the excessive use of 
soft drinks containing sugar, a further risk factor for 
caries development. Swallowing may become difficult 
in the cancer period due to the treatment related mu-
cositis, the ulcer caused by Herpes Simplex Virus type 
1 infection and the oral bleeding (18). For this reasons, 
cariogenic soft and sweet food are more frequently 
chosen. Moreover, mucosal and dental problems are 
often underestimated by the patients and their parents 
because of the severity of the underlying haematologic 
disease. Therefore, regular dental check-ups and related 
treatments remain often neglected. Even some dentist 
may be reluctant to provide an appropriate treatment for 
children with cancer because of unjustified fear of seri-
ous infection or bleeding. It is necessary the paediatric 
dentists make regular inspections of the oral conditions 
of children at least 24 months after healing in order to 
avoid and prevent dental and mucosal diseases related to 
leukaemia and its treatment. Other studies documented 
various pathologic oral and dental malformations in pa-
tients treated for malignant diseases: V-shaped roots, 
microdontia, and agenesis were the most common find-
ings in addition to enamel hypoplasia (4-9,13,14).
Children affected by haemathological diseases requires 
special attentions and dental care in addition to the an-
tineoplastic treatment. Oral hygiene and oral health can 
be maintained thanks to a close cooperation between the 
paediatric oncohaematologists, paediatrics, dental sur-
geons and dental hygienists. Our experience suggests that 
the side effects of antineoplastic therapy are unavoidable. 
However, it is important to increase the quality of life of 
children affected by ALL and AML in order to prevent 
the detrimental impact on the oral health.
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